Ab Science company information, Employees & Contact Information

AB Science provides intitial Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia Yahoo Finance

AB Science announces the successful completion of a EUR 2.8 million private placement GlobeNewswire

AB Science Reports Key Developments and Financial Results TipRanks

AB Science today reports its revenues for the first half of 2025 and provides an update on its activities Yahoo Finance

Why Your A/B Test Winner Might Just Be Random Noise Towards Data Science

AB Science will publish its 2024 annual financial report on May 9, 2025 FinancialContent

5 best ab rollers for carving an iron core, tried and tested by our fitness experts Live Science

AB Science Gets Go-Ahead for Phase 3 Study of Masitinib in ALS NeurologyLive

FDA and EMA authorise AB Science’s Phase III trial of prostate cancer treatment Clinical Trials Arena

AB Science expects negative opinion on application of ALS therapy masitinib ALS News Today

AB Science gets approval to start ALS drug confirmatory trial in Europe Investing.com

AB Science to win patent covering medical use of masitinib for SCD Sickle Cell Disease News

1,600-year-old tomb of Maya city's first ruler unearthed in Belize Live Science

AB Science has received approval from several European countries to initiate the confirmatory phase 3 study of masitinib in ALS Yahoo Finance

AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase 3 trial in metastatic castrate-resistant prostate cancer Yahoo Finance

AB Science provides an update on the renegotiation of loan repayment terms with its financial creditors Yahoo Finance

AB Science will hold a virtual conference on Thursday, October 16, 2025 from 2pm to 3pm CET to provide an update on the Phase 1 study with AB8939 Yahoo Finance

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS Yahoo Finance

AB Science reports promising phase 1 data for leukemia treatment Investing.com

AB Science touts positive Phase II Covid-19 data for masitinib Clinical Trials Arena

AB Science reports positive early data on leukemia drug combination Investing.com

Phase 3 trial of masitinib for ALS set to be launched by AB Science ALS News Today

Ab Science’s Phase 3 ALS Trial: A Key Development for Investors TipRanks

AB Science Publishes the Positive Phase 2/3 Clinical Trial of Masitinib in ALS The ALS Association

Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis Neurology® Journals

AB halts masitinib trials after discovering heart disease worry Fierce Biotech

What I learned after running AB tests for one year as a data scientist – Part 1/2 Towards Data Science

Can AB Science S.A. (A8D) stock sustain revenue momentum - Market Growth Report & Low Volatility Stock Recommendations newser.com

AB Science receives FDA and EMA authorization for phase 3 Trial of prostate cancer treatment Indian Pharma Post

Global Roundup: Sputnik V Adapted, AB Science Submits ALS Drug in EU and More BioSpace

Scientists convert a kidney from blood type A to universal type O and implant it in a brain-dead recipient Live Science

Bayesian A/B Testing Falls Short Towards Data Science

You Didn’t Conduct an A/B Test. You Can Still Simulate One Retrospectively. Towards Data Science

Is AB Science S.A.'s (EPA:AB) CEO Pay Justified? Yahoo Finance

GoFit Super Ab Wheel review Live Science

GymShark Ab Roller review Live Science

Keeping Time: The Origin of B.C. & A.D. Live Science

AB Science trumpets phase 3 ALS data, but investors seem unmoved Fierce Biotech

What Hypothesis Test Should I Use for My A/B Experiment? Towards Data Science

How to Optimize your Switchback A/B Test Configuration Towards Data Science

AI technologies for education: Recent research & future directions ScienceDirect.com

Bayesian AB Testing – Part III – Test Duration Towards Data Science

Another look at measures of forecast accuracy ScienceDirect.com